Brandie Morgan-Jack
09-06-23
Dr. Brandie Morgan-Jack is a member of the Neurodegenerative Diseases Research Laboratory (NDRL), which is dedicated to discovering the causes of and developing treatments for diseases that involve degenerative changes of the nervous system, including the retina, brain, spinal cord, and peripheral nerves.
Read More
Rebecca Whiting
09-11-19
Ex vivo gene therapy for treatment of CLN2 Batten disease using a canine model. We are pursuing combined treatment of the brain and retina to achieve amelioration of all neurologic symptoms in this disease. To learn more about my lab, click here.
Read More
Lixing Reneker
09-11-19
Dr. Lixing Reneker investigates signal transduction pathways in lens development as well as factors controlling corneal endothelial cell formation and differentiation.
Read More
Michael J. Petris
09-11-19
Dr. Michael Petris characterizes how changes in metal ion homeostasis contribute to Alzheimer’s disease with an emphasis on inflammation.
Read More
Martin L Katz
09-11-19
Dr. Martin Katz leads the Neurodegenerative Diseases Research Laboratory. He is interested in developing therapies for neurodegenerative disorders, with particular emphasis on the hereditary neuronal ceroid-lipofusconoses (NCLs) and amyotrophic lateral sclerosis (ALS).
Read More
Hu Huang
09-11-19
Dr. Hu Huang’s primary focus involves the study of the retina (a metabolically active tissue that senses light). Dysregulation of metabolism results in retinal cell dysfunction and miscommunication, subsequent cell death and vision loss.
Read More
